Sule A. Turkoglu
Bolu, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Analyzing multiple-sclerosis progression: stage-specific biomarker insights via explainable machine learning.
Journal: Neurodegenerative disease management
Published: April 02, 2026
Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis.
Journal: Journal of neuroimmunology
Published: November 25, 2025
Sexual dysfunction in multiple sclerosis: the role of orexin-A and calpain-2 - a pilot study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 02, 2025
Trends and global productivity in artificial intelligence research in clinical neurology and neuroimaging: a bibliometric analysis from 1980 to 2024.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: October 03, 2024
CXCL13 levels in cerebrospinal fluid in relapsing-remitting multiple sclerosis: The role of Borrelia in neuroinfections.
Journal: Journal of vector borne diseases
Published: July 18, 2024
Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study.
Journal: Multiple sclerosis and related disorders
Published: June 03, 2024
Is increased activator protein 1 in cerebrospinal fluid as a potential biomarker that distinguishes idiopathic intracranial hypertension from multiple sclerosis?
Journal: Bratislavske lekarske listy
Published: May 17, 2024
The effect of the HMGB1/RAGE/TLR4/NF-κB signalling pathway in patients with idiopathic epilepsy and its relationship with toxoplasmosis.
Journal: Journal of cellular and molecular medicine
Published: April 23, 2024
Recurring disease activity in relapsing remitting multiple sclerosis: The multicenter RDA-RMS study.
Recurring disease activity in relapsing remitting multiple sclerosis: The multicenter RDA-RMS study.
Journal: Multiple sclerosis and related disorders
Published: February 14, 2024
The incidence of deep venous thrombosis in Parkinson's disease.
Journal: Neurological research
Published: September 12, 2023
Erratum: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Journal: Noro psikiyatri arsivi
Published: June 08, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Journal: Noro psikiyatri arsivi
Published: December 11, 2021
Last Updated: 09/26/2026